• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旧疾新思:戈谢病、免疫与炎症。

Old disease-New reflections: Gaucher, immunity, and inflammation.

机构信息

Department of Medical Biotechnology, Acıbadem Mehmet Ali Aydınlar University, Institute of Health Sciences, Istanbul, Turkey.

Department of Basic Sciences, Dentistry Faculty, Istanbul Kent University, Istanbul, Turkey.

出版信息

J Cell Mol Med. 2024 Oct;28(20):e70087. doi: 10.1111/jcmm.70087.

DOI:10.1111/jcmm.70087
PMID:39463025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11513444/
Abstract

Gaucher disease (GD) is the most common lysosomal storage disease. It is a multisystemic metabolic disease caused by GBA pathogenic mutations. Although the general symptoms have been known for a long time, new treatment possibilities, the detection of different biomarkers, and innovations in diagnosis and follow-up have paved the way for further studies. Recent studies have shown that the immune system has become an essential factor associated with disease progression. The role of Gaucher cells in the disease is well characterized. In addition to phagocytic macrophage cells, lymphocytes, complement system, and inflammatory pathway elements are also implicated in GD as they were shown to be the underlying factors causing associated pathologies such as Parkinson's. In this article, the relationship between the GD and the immune system has been examined and reviewed in light of new findings.

摘要

戈谢病(GD)是最常见的溶酶体贮积症。它是一种由 GBA 致病突变引起的多系统代谢性疾病。尽管一般症状已经为人熟知,但新的治疗可能性、不同生物标志物的检测以及诊断和随访方面的创新为进一步研究铺平了道路。最近的研究表明,免疫系统已成为与疾病进展相关的重要因素。戈谢细胞在疾病中的作用已经得到很好的描述。除了吞噬性巨噬细胞外,淋巴细胞、补体系统和炎症途径成分也与 GD 有关,因为它们被证明是导致帕金森病等相关病理的潜在因素。在本文中,根据新的发现,研究了 GD 与免疫系统之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae69/11513444/49bdb981de2c/JCMM-28-e70087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae69/11513444/4a3be6e8f89e/JCMM-28-e70087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae69/11513444/49bdb981de2c/JCMM-28-e70087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae69/11513444/4a3be6e8f89e/JCMM-28-e70087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae69/11513444/49bdb981de2c/JCMM-28-e70087-g001.jpg

相似文献

1
Old disease-New reflections: Gaucher, immunity, and inflammation.旧疾新思:戈谢病、免疫与炎症。
J Cell Mol Med. 2024 Oct;28(20):e70087. doi: 10.1111/jcmm.70087.
2
An unexpected player in Gaucher disease: The multiple roles of complement in disease development.戈谢病的意外参与者:补体在疾病发展中的多重作用。
Semin Immunol. 2018 Jun;37:30-42. doi: 10.1016/j.smim.2018.02.006. Epub 2018 Feb 23.
3
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.氨溴索可改善葡萄糖脑苷脂酶突变相关帕金森病细胞的溶酶体生化特性。
Brain. 2014 May;137(Pt 5):1481-95. doi: 10.1093/brain/awu020. Epub 2014 Feb 25.
4
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.葡萄糖脑苷脂酶携带者伴或不伴帕金森病的细胞因子和 Gaucher 生物标志物。
Mov Disord. 2021 Jun;36(6):1451-1455. doi: 10.1002/mds.28525. Epub 2021 Feb 11.
5
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.补体驱动葡萄糖神经酰胺积累和戈谢病中的组织炎症。
Nature. 2017 Mar 2;543(7643):108-112. doi: 10.1038/nature21368. Epub 2017 Feb 22.
6
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).戈谢病:葡糖脑苷脂酶基因(GBA)中的突变和多态性谱
Hum Mutat. 2008 May;29(5):567-83. doi: 10.1002/humu.20676.
7
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.青鳉(Oryzias latipes)中可行的神经元型戈谢病模型显示α-突触核蛋白在轴突中积累。
PLoS Genet. 2015 Apr 2;11(4):e1005065. doi: 10.1371/journal.pgen.1005065. eCollection 2015 Apr.
8
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.溶酶体贮积症与帕金森病:戈谢病及其他。
Mov Disord. 2011 Aug 1;26(9):1593-604. doi: 10.1002/mds.23774. Epub 2011 May 26.
9
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
10
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.GBA 突变阳性队列中帕金森病前驱临床标志物的演变
JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.

引用本文的文献

1
CRISPR/Cas-Based Ex Vivo Gene Therapy and Lysosomal Storage Disorders: A Perspective Beyond Cas9.基于CRISPR/Cas的体外基因治疗与溶酶体贮积症:超越Cas9的视角
Cells. 2025 Jul 25;14(15):1147. doi: 10.3390/cells14151147.
2
Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects.高雪氏病中多能干细胞技术的当前观点:挑战与未来前景
Cytotechnology. 2025 Feb;77(1):26. doi: 10.1007/s10616-024-00687-2. Epub 2024 Dec 27.

本文引用的文献

1
Gaucher disease protects against tuberculosis.戈谢病可预防结核病。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2217673120. doi: 10.1073/pnas.2217673120. Epub 2023 Feb 6.
2
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.靶向 COVID-19 和戈谢病中的补体-鞘脂系统:一种新治疗策略的证据。
Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340.
3
Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey.
来自土耳其的黏多糖贮积症、戈谢病和庞贝病患者的真实世界患者免疫和 COVID-19 状况数据。
Arch Pediatr. 2022 Aug;29(6):415-423. doi: 10.1016/j.arcped.2022.05.003. Epub 2022 May 23.
4
Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease.戈谢氏病患儿细胞毒性 T 细胞的上调。
Sci Rep. 2022 Mar 23;12(1):4977. doi: 10.1038/s41598-022-08843-4.
5
Glycosphingolipids and neuroinflammation in Parkinson's disease.糖脂和帕金森病中的神经炎症。
Mol Neurodegener. 2020 Oct 17;15(1):59. doi: 10.1186/s13024-020-00408-1.
6
Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease.干扰素信号通路缺陷的小鼠有助于区分神经细胞型 Gaucher 病小鼠模型中的原发性和继发性病理途径。
J Neuroinflammation. 2020 Sep 7;17(1):265. doi: 10.1186/s12974-020-01934-x.
7
Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis.戈谢病神经病变形式中的固有免疫反应赋予了对病毒诱导的脑炎的抗性。
Acta Neuropathol Commun. 2020 Aug 24;8(1):144. doi: 10.1186/s40478-020-01020-6.
8
Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.戈谢病相关的间充质干细胞改变会减少成骨并促进成脂过程,同时增加破骨细胞生成。
Mol Genet Metab. 2020 Aug;130(4):274-282. doi: 10.1016/j.ymgme.2020.06.003. Epub 2020 Jun 8.
9
Downregulation of B regulatory cells and upregulation of T helper 1 cells in children with Gaucher disease undergoing enzyme replacement therapy.接受酶替代治疗的戈谢氏病患儿中 B 调节细胞下调和辅助性 T 细胞 1 上调。
Immunol Res. 2020 Apr;68(2):73-80. doi: 10.1007/s12026-020-09129-5.
10
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.